跳至主要内容
临床试验/JPRN-UMIN000013559
JPRN-UMIN000013559已完成未知

A prospective and multicenter trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis - Intravenous immunoglobulin therapy for IPF

Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine0 个研究点目标入组 10 人开始时间: 2014年3月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Coexisting or clinical suspicion of sarcoidosis, hypersensitivity pneumonitis, connective tissue diseases, pneumoconiosis, drug-induced pneumonitis, infectious disease, pregnancy, coexisting chronic obstructive pulmonary disease (COPD), bronchial asthma, bronchiectasis, neoplasm, severe cardiovascular disease, cerebrovascular disease, chronic kidney disease, or thromboembolism. Patients who were unable to undergo physiologic tests, unable to understand the protocol or provide written informed consent, or who were administered with 20 mg/day or more of predonisolone, immunosuppressive agents, antifibrotic agents, or immunoglobulin during the preceding 3 months

研究者

发起方
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine

相似试验